Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Saberi · SciRah

Researcher profile · Semantic Scholar

S. Saberi

Share profile

S. Saberi — researcher profile on SciRah

h-index: 41
Works: 227
Citations: 11K

Most-cited papers

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
S. Ommen, Carolyn Y. Ho, I. Asif, Seshadri Balaji +18 more
2024Circulation543 citations
Semantic Scholar
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
S. Ommen, Carolyn Y. Ho, I. Asif, Seshadri Balaji +18 more
2024Journal of the American College of Cardiology323 citations Open access
Semantic Scholar
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial.
M. Desai, A. Owens, K. Wolski, J. Geske +17 more
2023JAMA cardiology147 citations Open access
Semantic Scholar
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort.
Florian Rader, A. Oręziak, L. Choudhury, S. Saberi +13 more
2024JACC. Heart failure83 citations Open access
Semantic Scholar
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM
M. Desai, K. Wolski, A. Owens, J. Geske +15 more
2024Circulation67 citations
Semantic Scholar
Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.
A. Masri, M. Sherrid, Theodore P. Abraham, L. Choudhury +22 more
2024Journal of Cardiac Failure53 citations Open access
Semantic Scholar
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial.
M. Desai, Y. Okushi, K. Wolski, J. Geske +13 more
2024JACC Cardiovascular Imaging45 citations Open access
Semantic Scholar
Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial
M. Desai, Y. Okushi, A. Gaballa, Qiuqing Wang +14 more
2024Circulation Cardiovascular Imaging38 citations Open access
Semantic Scholar
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
S. Hegde, B. Claggett, Xiaowen Wang, K. Jering +20 more
2024Journal of the American College of Cardiology35 citations Open access
Semantic Scholar
Long-term Outcomes after Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy : Insights from the Share Registry
N. Maurizi, Panagiotis Anthiochos, Anjali Owens, Neal Lakdwala +25 more
2024Circulation35 citations Open access
Semantic Scholar
Atrial Fibrillation in Hypertrophic Cardiomyopathy
A. Weissler-Snir, S. Saberi, Timothy C. Wong, A. Pantazis +4 more
2024JACC: Advances26 citations Open access
Semantic Scholar
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM.
S. Saberi, T. Abraham, L. Choudhury, R. Barriales-Villa +22 more
2025JACC. Heart failure25 citations Open access
Semantic Scholar
Examining blockchain's role in supply chain finance structure and governance
Sang Hoo Bae, S. Saberi, Mahtab Kouhizadeh, Joseph Sarkis
2025International Review of Financial Analysis23 citations Open access
Semantic Scholar
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response
A. Owens, M. Desai, Matthew T. Wheeler, Anna Rodonski +3 more
2024Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease23 citations Open access
Semantic Scholar
Industry 4.0 Adoption Drivers for Sustainable Supply Chain in the Manufacturing Sector Using a Hybrid Decision-Making Approach Under q-Rung Orthopair Fuzzy Information
A. Mardani, S. Saberi
2024IEEE transactions on engineering management22 citations
Semantic Scholar
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy
Charles F. Sherrod, S. Saberi, M. Nassif, B. Claggett +17 more
2024Journal of the American College of Cardiology20 citations Open access
Semantic Scholar
Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy
Joshua K. Meisner, Aaron Renberg, Eric D. Smith, Yao-Chang Tsan +28 more
2024Circulation19 citations Open access
Semantic Scholar
Safety and efficacy of aficamten in patients with non‐obstructive hypertrophic cardiomyopathy: A 36‐week analysis from FOREST‐HCM
A. Masri, R. Barriales-Villa, P. Elliott, M. Nassif +10 more
2024European Journal of Heart Failure19 citations Open access
Semantic Scholar
Evaluating blockchain technology adoption in multi-tier supply chains from an institutional entrepreneurship theory perspective
Sang Hoo Bae, S. Saberi, Mahtab Kouhizadeh, Joseph Sarkis
2024Transportation Research Part C: Emerging Technologies17 citations
Semantic Scholar
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCM
C. Coats, A. Masri, M. Nassif, R. Barriales-Villa +140 more
2024Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease16 citations Open access
Semantic Scholar
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM.
A. Masri, L. Choudhury, R. Barriales-Villa, P. Elliott +20 more
2024Journal of the American College of Cardiology16 citations Open access
Semantic Scholar
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry
Sarah Abou Alaiwi, T. Roston, Peter Marstrand, B. Claggett +21 more
2023Circulation14 citations Open access
Semantic Scholar
Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis
I. Landsteiner, A. Masri, S. Saberi, M. Maron +6 more
2025Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease13 citations Open access
Semantic Scholar
Genetic constraint at single amino acid resolution in protein domains improves missense variant prioritisation and gene discovery
Xiaolei Zhang, P. Theotokis, Nicholas Li, E. Ashley +20 more
2024Genome Medicine13 citations Open access
Semantic Scholar
Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial.
M. Desai, Anjali Owens, K. Wolski, J. Geske +18 more
2024Journal of the American College of Cardiology13 citations Open access
Semantic Scholar
Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy: Insight from the VALOR-HCM Study.
Paul C. Cremer, J. Geske, Anjali Owens, Wael A. Jaber +13 more
2024JACC Cardiovascular Imaging12 citations Open access
Semantic Scholar
A neutrosophic optimization model for supply chain virtualization in the circular economy using the non-dominated sorting genetic algorithm II
Hanieh Shambayati, Mohsen Shafiei Nikabadi, S. Saberi, A. Mardani
2024Annals of Operations Research11 citations
Semantic Scholar
Association between age or duration of diagnosis in obstructive hypertrophic cardiomyopathy and response to mavacamten treatment: Exploratory analysis of the EXPLORER-HCM trial.
Andrew Wang, N. Lakdawala, Theodore P. Abraham, E. Nilles +6 more
2024Journal of Cardiac Failure11 citations
Semantic Scholar
The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic Cardiomyopathy.
M. Ahluwalia, Jian-Kang Liu, I. Olivotto, V. Parikh +18 more
2024JACC. Heart failure10 citations Open access
Semantic Scholar
Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for up to 128 Weeks: Insights From the VALOR-HCM Trial.
M. Desai, Y. Okushi, K. Wolski, J. Geske +14 more
2025JACC Cardiovascular Imaging9 citations
Semantic Scholar
Robust tobacco smoking self-report in two cohorts: pregnant women or men and women living with or without HIV
Marie-Soleil R. Smith, S. Saberi, Abhinav Ajaykumar, Mayanne Zhu +10 more
2023Scientific Reports8 citations Open access
Semantic Scholar
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy
A. Butters, C. Arnott, J. Sweeting, B. Claggett +23 more
2023medRxiv7 citations Open access
Semantic Scholar
LONG-TERM EFFICACY AND SAFETY OF AFICAMTEN IN PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
S. Saberi, T. Abraham, L. Choudhury, A. Owens +16 more
2023Journal of the American College of Cardiology7 citations Open access
Semantic Scholar
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy.
C. Vissing, A. Axelsson Raja, A. Helms, S. Saberi +18 more
2026Circulation6 citations Open access
Semantic Scholar
LONG-TERM FAVORABLE CARDIAC REMODELING IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY PATIENTS TREATED WITH MAVACAMTEN FOR UP TO 128 WEEKS: INSIGHTS FROM VALOR-HCM TRIAL
M. Desai, Y. Okushi, J. Geske, A. T. Owens +14 more
2025Journal of the American College of Cardiology6 citations Open access
Semantic Scholar
Genetic testing and counseling for hypertrophic cardiomyopathy: An evidence‐based practice resource of the National Society of Genetic Counselors
Erin M. Miller, E. Brown, S. Christian, Melissa A. Kelly +4 more
2024Journal of Genetic Counseling6 citations Open access
Semantic Scholar
Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry.
C. Topriceanu, I. Balakrishnan, C. Vissing, A. A. Raja +26 more
2026Journal of the American College of Cardiology5 citations
Semantic Scholar
Long-term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights from VALOR-HCM Trial.
M. Desai, A. Owens, S. Saberi, Andrew Wang +11 more
2025Circulation Genomic and Precision Medicine5 citations
Semantic Scholar
Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM.
A. Masri, M. Sherrid, L. Choudhury, P. García-Pavía +19 more
2025Journal of Cardiac Failure5 citations Open access
Semantic Scholar
Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.
M. Desai, S. Saberi, J. Geske, Andrew Wang +8 more
2025JACC. Heart failure5 citations Open access
Semantic Scholar
Aficamten in patients with obstructive hypertrophic cardiomyopathy: an integrated safety analysis
A. Masri, R. Barriales-Villa, P. Elliott, M. Nassif +11 more
2024European Heart Journal5 citations Open access
Semantic Scholar
Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM
S. Arnold, K. Gosch, Chantal Dolan, J. Fine +10 more
2024Circulation5 citations
Semantic Scholar
RBM20 Truncating Variants and Human Cardiomyopathy.
B. Floyd, Joyce N. Njoroge, Vikki A. Krysov, B. Gomes +44 more
2026JAMA cardiology4 citations Open access
Semantic Scholar
Low Incidence of Atrial Fibrillation in Patients with Obstructive HCM Treated with Aficamten: An Analysis from the REDWOOD-HCM, SEQUOIA-HCM and FOREST-HCM Trials.
E. Rowin, M. Maron, I. Olivotto, C. Coats +11 more
2025Heart Rhythm4 citations Open access
Semantic Scholar
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
A. Masri, M. Maron, T. Abraham, M. Nassif +17 more
2025JACC. Heart failure4 citations Open access
Semantic Scholar
Qualitative interview study of patient-reported symptoms, impacts and treatment goals of patients with obstructive hypertrophic cardiomyopathy
Supriya Shore, C. Ervin, K. Kosa, S. Fehnel +5 more
2024BMJ Open4 citations Open access
Semantic Scholar
EFFICACY AND SAFETY OF AFICAMTEN IN THE FIRST COHORT OF PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY COMPLETING 1-YEAR FOLLOW-UP: FINDINGS FROM THE FOREST-HCM STUDY
S. Saberi, T. Abraham, L. Choudhury, A. T. Owens +17 more
2024Journal of the American College of Cardiology4 citations Open access
Semantic Scholar
Efficacy And Safety Of Aficamten In Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From The Randomized Evaluation Of Dosing With Ck-3773274 In Hypertrophic Cardiomyopathy Open Label Extension Study
A. Masri, T. Abraham, L. Choudhury, A. Owens +17 more
2023Journal of Cardiac Failure3 citations
Semantic Scholar
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study
A. Tower-Rader, A. Masri, M. Nassif, Theodore P. Abraham +18 more
2026European Heart Journal2 citations Open access
Semantic Scholar
The contribution of RBM20 truncating variants to human cardiomyopathy
B. Floyd, Joyce N. Njoroge, Vikki A. Krysov, Bruna Gomes +43 more
2025medRxiv2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Olivotto×21
Invite
I. Olivotto — researcher profile on SciRah
A. Tower-Rader×18
Invite
A. Tower-Rader — researcher profile on SciRah
N. Lakdawala×17
Invite
N. Lakdawala — researcher profile on SciRah
A. Masri×16
Invite
A. Masri — researcher profile on SciRah

×16

Invite

S. Heitner — researcher profile on SciRah

Invite

M. Sherrid — researcher profile on SciRah

Invite

S. Kupfer — researcher profile on SciRah

Invite

D. Jacoby — researcher profile on SciRah

Invite

S. Naidu — researcher profile on SciRah

Invite

J. Geske — researcher profile on SciRah

Invite

A. Sehnert — researcher profile on SciRah

R. Barriales-Villa×11

Invite

R. Barriales-Villa — researcher profile on SciRah